Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS and Y2K

This article was originally published in The Tan Sheet

Executive Summary

A memorandum entitled "HHS Progress in Health-Related Y2K Issues," penned by HHS Deputy Secretary Kevin Thurm, maintains that "prescription and nonprescription drugs will be available during the Year 2000 transition period." The Aug. 31 memo to HHS employees notes industry normally has a 90-day supply available and already has back-up plans for events such as bad weather and transportation delays. However, all priority drug manufacturers will be assessed, he states, as well as a random sampling of non-priority manufacturers. Regarding infant formula and medical foods, Thurm says manufacturers have been contacted and began submitting self assessments and contingency plans to FDA in mid-July
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090280

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel